- Categories:Innovation Collaboration Platform
- Time of issue:2020-01-23 00:00:00
Viwit platform provides CDMO services of APIs and intermediates, oral solids (tablets, capsules), sterile liquid products (small volume injections-ampoules, vials, eye drops). The production facilities comply with the cGMP regulations of China's NMPA, US FDA and EU EMA.
The platform's existing CDMO resources include:
1. API facility that was successfully audited by US FDA and Health Canada;
2. US FDA cGMP oral solids production facility that can produce tablets, capsules and other dosage forms;
3. Sterile injectables (ampoules) facility that was GMP certified by China NMPA;
4. Production workshops for injectables (vials) and opthalmic eye drops (single-dose and multi-dose) which are being built in accordance with FDA standards
The CDMO services currently available on the platform include:
1. R&D services
1) Contract R&D of FDFs: tablets and capsules (IR/ER/DR), injections, eye drops, nano/microsphere products;
2) Contract R&D of APIs: chemically synthesized APIs or semi-synthetic APIs;
3) Contract R&D of intermediates for innovative medicines.
2. Contract production services of
1) FDFs: tablets, capsules, oral powders, injections;
2) APIs: chemically synthesized APIs or semi-synthetic APIs;
3) Pharmaceutical intermediates.
Scan the QR code to read on your phone